There are currently 3 active clinical trials seeking participants for Fabry Disease research studies. The states with the highest number of trials for Fabry Disease participants are .
Fabry Disease Registry & Pregnancy Sub-registry
Recruiting
The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary objectives of the Registry are: * To enhance the understanding of the variability, progression, and natural history of F... Read More
Gender:
ALL
Ages:
All
Trial Updated:
08/07/2025
Locations: University of Alabama Birmingham- Nephrology- Site Number : 840018, Birmingham, Alabama +275 locations
Conditions: Fabry Disease
Canadian Fabry Disease Initiative (CFDI) National Registry
Recruiting
CFDI NATIONAL REGISTRY Fabry disease is a rare, inherited, genetic condition due to a deficiency of an enzyme called alpha-galactosidase A. This enzyme deficiency causes the small blood vessels to accumulate a substance called glycolipid. Without sufficient levels of the enzyme, alpha-galactosidase A, persons with Fabry Disease develop severe neuropathic pain, kidney disease, heart disease, stroke and/or premature death; often before the age of 60. Fabry Disease is estimated to affect approxim... Read More
Gender:
ALL
Ages:
Between 5 years and 85 years
Trial Updated:
02/14/2024
Locations: Alberta Children's Hospital, Calgary, Alberta +4 locations
Conditions: Fabry Disease
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Recruiting
This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of adverse events.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2023
Locations: University Health Network, Toronto, Ontario
Conditions: Fabry Disease